X5 Retail Group NV (LON:FIVE)

TheStreet.com  Mar 26  Comment 
NEW YORK (TheStreet) -- Five Below  is soaring on Wednesday after reporting revenue and earnings growth over the three months to Feb. 1, one of the few retailers to do so over a holiday season more aggressively promotional than normal. By...
StreetInsider.com  Mar 25  Comment 
Five Below (NASDAQ: FIVE) 14.9% HIGHER; reported Q4 EPS of $0.47, $0.02 better than the analyst estimate of $0.45. Revenue for the quarter came in at $212 million versus the consensus estimate of $207.98 million. Five Below sees Q1 2014 EPS of...
TheStreet.com  Mar 25  Comment 
NEW YORK (TheStreet) -- Five Below  surged in extended trading after posting better-than-expected results on the top- and bottom-line over the three months to Feb. 1. After the bell, shares had added 14.1% to $43.37. The discounts chain...
StreetInsider.com  Mar 25  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Earnings/Five+Below+%28FIVE%29+Tops+Q4+EPS+by+2c%2C+Offers+Guidance/9315260.html for the full story.
The Australian  Mar 24  Comment 
FIVE former employees of Bernie Madoff have been found guilty of helping the Wall Street fraudster run his giant Ponzi scheme.
StreetInsider.com  Jan 23  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Upgrades/Barclays+Upgrades+Five+Below+%28FIVE%29+to+Overweight/9080754.html for the full story.
SeekingAlpha  Jan 13  Comment 
By Brian Sanders: Hindsight View Back in August, I recommended Five Below (FIVE) as a decent company worthy of investment because of their consistent store expansion and strong revenue growth Some investors were speculating that if the...
TheStreet.com  Jan 10  Comment 
SAN DIEGO (TheStreet) -- It happens all the time: Investors get blindsided and wonder why. Classic case: Five Below . This is one I've been hearing about as a disaster-in-the-making for months, but hadn't yet focused on or written about. Still,...
TheStreet.com  Jan 10  Comment 
NEW YORK (TheStreet) -- Five Below  continued its losses over Friday's session after posting disappointing holiday sales performance a day earlier. By early afternoon, the stock had shed 6.9% to $40.57. On Thursday after the bell, the retailer...
StreetInsider.com  Jan 10  Comment 
Intercept Pharmaceuticals, Inc. (Nasdaq: ICPT) 25% HIGHER; continues higher after Thursday's 281% surge after its FLINT trial of obeticholic acid (OCA) for the treatment of nonalcoholic steatohepatitis (NASH) was stopped early for efficacy based...


Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki